VisionCare Ophthalmic Technologies (Saratoga, California) have announced that their FDA-approved Implantable Miniature Telescope (IMT) has been implanted into the first patient. The IMT device is indicated for monocular implantation in patients 75 years of older who are diagnosed with stable severe to profound visual impairment caused by bilateral central scotomas associated with end-stage AMD. According to the company the device is “smaller than a pea” and can be implanted in one eye in an outpatient surgical procedure. The device is designed to render enlarged central vision images over a wide area of the retina to improve central vision, leaving the non-operated eye for peripheral vision, mobility and orientation.